Warning:
JavaScript is turned OFF. None of the links on this page will work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map has information related to: Chapter 16, drugs e.g. rapamycin, drugs must be tested in trials of Phase II, cancer treatment targets differentiation, modern diagnoses which relies on genetic markers, cancer treatment targets mitotic catastrophe, drugs must be tested in trials of Phase III, genotypic/phenotypic plasticity yields biochemical redundancy, cancer treatment may be based on modern diagnoses, drugs e.g. Gleevec, histology without regard to the potential for metastasis